WuXi AppTec
WuXi AppTec
WuXi AppTec (stock code: 603259.SH/2359.HK) provides integrated, end-to-end new drug research and development and production services to the global biopharmaceutical industry, and has operating bases in Asia, Europe, North America and other places. WuXi AppTec continuously lowers R&D threshold through its unique "CRDMO" and "CTDMO" business models, helps customers improve R&D efficiency and brings more breakthrough treatment plans to patients. Its service scope covers chemical drug research and development, production, and biology. Research, preclinical testing and clinical trial research and development, cell and gene therapy research and development, testing and production and other fields. In 2022, WuXi AppTec was rated as ESG (Environmental, Social and Governance) AA by MSCI. At present, the company's empowerment platform is carrying R&D and innovative projects from more than 5,950 partners from more than 30 countries around the world, and is committed to bringing more new and good drugs to patients around the world, so as to achieve "making the world without any difficulties" as soon as possible The vision of medicine, difficult to cure diseases.
Brand: FOSHAN PHARMA
Main Products: Tetanus Antitoxin Injection , Tetanus Antiserum , Human Hepatitis B Immunoglobulin , Oxytocin Injection , Natural essential oil , Biological Product For Human
Shaanxi YXchuang Biotechnology Co., Ltd
Brand: YXchuang
Main Products: API Powder , Pharmaceutical Intermediates , Vitamins Powder , Plant Extracts , Food Additive , Peptide Powder
Brand: NOUVASANT
Main Products: Finished Pharmaceutical Product , API & Raw materials , Antimalarial , Antibiotic & Antimicrobial , Medical Disposables , Antifungal Drugs
NANYANG CHENGPENG PHARMACEUTICAL CO.,LTD
Brand: CHENGPENG
Main Products: Veterinary APIS , Veterinary Premix APIs , Veterinary Soluble Powder , Feed Additives , Food Additives , Extracts for Animal
